West Pharmaceutical Services (NYSE: WST) is one of 84 public companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it weigh in compared to its competitors? We will compare West Pharmaceutical Services to related companies based on the strength of its valuation, institutional ownership, analyst recommendations, earnings, dividends, risk and profitability.
West Pharmaceutical Services pays an annual dividend of $0.52 per share and has a dividend yield of 0.5%. West Pharmaceutical Services pays out 22.2% of its earnings in the form of a dividend. As a group, “Medical Equipment, Supplies & Distribution” companies pay a dividend yield of 0.8% and pay out 37.3% of their earnings in the form of a dividend. West Pharmaceutical Services has increased its dividend for 24 consecutive years.
This table compares West Pharmaceutical Services and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|West Pharmaceutical Services||11.42%||14.02%||9.32%|
|West Pharmaceutical Services Competitors||-127.09%||-36.26%||-10.19%|
Valuation and Earnings
This table compares West Pharmaceutical Services and its competitors top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|West Pharmaceutical Services||$1.54 billion||$317.90 million||40.62|
|West Pharmaceutical Services Competitors||$827.23 million||$159.49 million||36.37|
West Pharmaceutical Services has higher revenue and earnings than its competitors. West Pharmaceutical Services is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
This is a summary of recent ratings and target prices for West Pharmaceutical Services and its competitors, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|West Pharmaceutical Services||0||1||3||0||2.75|
|West Pharmaceutical Services Competitors||171||1125||2462||89||2.64|
West Pharmaceutical Services currently has a consensus price target of $107.00, indicating a potential upside of 12.56%. As a group, “Medical Equipment, Supplies & Distribution” companies have a potential upside of 9.22%. Given West Pharmaceutical Services’ stronger consensus rating and higher probable upside, equities analysts clearly believe West Pharmaceutical Services is more favorable than its competitors.
Risk & Volatility
West Pharmaceutical Services has a beta of 1.12, indicating that its stock price is 12% more volatile than the S&P 500. Comparatively, West Pharmaceutical Services’ competitors have a beta of 1.06, indicating that their average stock price is 6% more volatile than the S&P 500.
Insider & Institutional Ownership
90.6% of West Pharmaceutical Services shares are held by institutional investors. Comparatively, 63.1% of shares of all “Medical Equipment, Supplies & Distribution” companies are held by institutional investors. 1.9% of West Pharmaceutical Services shares are held by company insiders. Comparatively, 13.0% of shares of all “Medical Equipment, Supplies & Distribution” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
West Pharmaceutical Services beats its competitors on 12 of the 15 factors compared.
About West Pharmaceutical Services
West Pharmaceutical Services, Inc. is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services. The Company’s segments include Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment develops commercial and operational strategies across its global network, with specific emphasis on product offerings to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as an integrated business focused on the design, manufacture and automated assembly of various devices, primarily for pharmaceutical, diagnostic and medical device customers.
Receive News & Ratings for West Pharmaceutical Services Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services Inc. and related companies with MarketBeat.com's FREE daily email newsletter.